{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT03059121",
            "orgStudyIdInfo": {
                "id": "06-16-19"
            },
            "organization": {
                "fullName": "University Hospitals Cleveland Medical Center",
                "class": "OTHER"
            },
            "briefTitle": "The Cleveland Cardiometabolic Cohort",
            "officialTitle": "Observational Study of Cardiometabolic Risk in HIV Infected Subjects After Initiation of Antiretroviral Therapy: The Cleveland Cardiometabolic Cohort",
            "therapeuticArea": [
                "Infectious Diseases",
                "Other"
            ],
            "study": "the-cleveland-cardiometabolic-cohort"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-02",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2016-09",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2017-02-10",
            "studyFirstSubmitQcDate": "2017-02-15",
            "studyFirstPostDateStruct": {
                "date": "2017-02-23",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-02-06",
            "lastUpdatePostDateStruct": {
                "date": "2024-02-07",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR_INVESTIGATOR",
                "investigatorFullName": "Grace McComsey",
                "investigatorTitle": "Principle Investigator",
                "investigatorAffiliation": "University Hospitals Cleveland Medical Center"
            },
            "leadSponsor": {
                "name": "Grace McComsey",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false
        },
        "descriptionModule": {
            "briefSummary": "In this observational study, the investigators will examine the changes in body composition in HIV-infected subjects before and after initiation of HIV treatment, and look at the correlations with changes in cardiometabolic indices such as endothelial function and coronary calcium scoring.",
            "detailedDescription": "The effects of lifestyle factors on body composition changes after antiretroviral therapy (ART) are unknown, and as such, investigators will use this prospective observational cohort to study relationships between lifestyle factors, including diet, physical activity and illicit drug use, with changes in body composition after ART. In addition, the effect of the body fat changes will be correlated to changes in cardiometabolic indices such as endothelial function and coronary calcium scoring."
        },
        "conditionsModule": {
            "conditions": [
                "HIV",
                "Lipodystrophy"
            ],
            "keywords": [
                "HIV",
                "Lipodystrophy"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "bioSpec": {
                "retention": "SAMPLES_WITH_DNA",
                "description": "Urine, plasma, feces"
            },
            "enrollmentInfo": {
                "count": 60,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "HIV-infected ART-na\u00efve",
                    "description": "HIV-infected subjects \u2265 16 years who are ART-na\u00efve starting their first antiretroviral regimen",
                    "interventionNames": [
                        "Diagnostic Test: Dual-energy X-ray absorptiometry"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DIAGNOSTIC_TEST",
                    "name": "Dual-energy X-ray absorptiometry",
                    "armGroupLabels": [
                        "HIV-infected ART-na\u00efve"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Body composition measures",
                    "description": "Assessed using DEXA (dual energy x-ray absorptiometry) scans which will be quantifying total body fat",
                    "timeFrame": "Baseline, 6-month, 1 year, 2 year, 3 year, 4 year, 5 year"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Resting Energy Expenditure (REE) measures",
                    "description": "Assessed using a BodyGem REE calculator (values in KCal)",
                    "timeFrame": "Baseline, 6-month, 1 year, 2 year, 3 year, 4 year, 5 year"
                },
                {
                    "measure": "endothelial function measures",
                    "description": "Assessed using EndoPAT (values reported as a reactive hyperemia index RHI)",
                    "timeFrame": "Baseline, 6-month, 1 year, 2 year, 3 year, 4 year, 5 year"
                },
                {
                    "measure": "calcium score measures",
                    "description": "Assessed using CT scans",
                    "timeFrame": "Baseline, 6-month, 1 year, 2 year, 3 year, 4 year, 5 year"
                },
                {
                    "measure": "central obesity",
                    "description": "measured with waist circumference using a tape measure (in cm)",
                    "timeFrame": "Baseline, 6-month, 1 year, 2 year, 3 year, 4 year, 5 year"
                },
                {
                    "measure": "Lipids measures",
                    "description": "used measuring blood levels of triglycerides (mg/dL); serum high-density lipoprotein (mg/dL) ; cholesterol (mg/dL); low density lipoprotein (mg/dL)",
                    "timeFrame": "Baseline, 6-month, 1 year, 2 year, 3 year, 4 year, 5 year"
                },
                {
                    "measure": "Fasting plasma glucose measures",
                    "description": "fasting plasma glucose test is performed after a person has fasted for at least 8 hours (measured in mg/dL)",
                    "timeFrame": "Baseline, 6-month, 1 year, 2 year, 3 year, 4 year, 5 year"
                },
                {
                    "measure": "Metabolic syndrome",
                    "description": "Metabolic syndrome will be defined using the following measures: central obesity, serum triglycerides , serum high-density lipoprotein (HDL); cholesterol levels and fasting plasma glucose",
                    "timeFrame": "Baseline, 6-month, 1 year, 2 year, 3 year, 4 year, 5 year"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* HIV-1 infection as documented by any licensed ELISA test kit and confirmed by Western blot at any time prior to study entry. HIV-1 culture, HIV-1 antigen, plasma HIV-1 RNA, or a second antibody test by a method other than ELISA is acceptable as an alternative confirmatory test\n* Provides written informed consent and is capable of reading and comprehending the informed consent\n* Is not currently taking antiretroviral therapy and has never been on such treatments in the past. Exception would be for subjects who had been in the past on \u226430 days cumulative antiretrovirals, as long as these were stopped \\>6 months prior to study entry\n* Is planning on starting antiretroviral therapy as part of routine clinic care\n\nExclusion Criteria:\n\n* Pregnancy or lactation",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "16 Years",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "Subjects will be primarily recruited from the practice of the investigator (the Special Immunology Unit (SIU) at University Hospitals Case Medical Center). All subjects seen at the Special Immunology Unit who meet the inclusion/exclusion criteria will be approached for study participation. Subjects who see physicians outside of the SIU may be eligible as well if they contact the study team and meet the inclusion criteria.",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Danielle Labbato, BSN",
                    "role": "CONTACT",
                    "phone": "216-844-2739",
                    "email": "danielle.labbato@uhhospitals.org"
                },
                {
                    "name": "Grace McComsey, MD",
                    "role": "CONTACT",
                    "email": "mccomsey.grace@clevelandactu.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Grace McComsey, MD",
                    "affiliation": "University Hospitals Cleveland Medical Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University Hospitals Case Medical Center",
                    "status": "RECRUITING",
                    "city": "Cleveland",
                    "state": "Ohio",
                    "zip": "44106",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Danielle Labbato, BSN",
                            "role": "CONTACT",
                            "phone": "216-844-2739",
                            "email": "danielle.labbato@uhhospitals.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.4995,
                        "lon": -81.69541
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008060",
                    "term": "Lipodystrophy"
                }
            ],
            "ancestors": [
                {
                    "id": "D000012875",
                    "term": "Skin Diseases, Metabolic"
                },
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                },
                {
                    "id": "D000052439",
                    "term": "Lipid Metabolism Disorders"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3522",
                    "name": "Acquired Immunodeficiency Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M18250",
                    "name": "HIV Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M11060",
                    "name": "Lipodystrophy",
                    "asFound": "Lipodystrophy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15678",
                    "name": "Skin Diseases, Metabolic",
                    "relevance": "LOW"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27029",
                    "name": "Lipid Metabolism Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC01",
                    "name": "Infections"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M25428",
                    "name": "Anti-Retroviral Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}